Assignee
IMMUNOFORGE CO LTD
KR·2 granted patents·8 pending applications·1 citations·filing 2016–2025
Top patents by PatentIndex Score
10 records- 0181US2025325635A1Modified vasoactive intestinal peptidesIMMUNOFORGE CO LTD·Filed 2024·Application pending·0 cites
- 0277US2025332221A1Methods and compositions for treating muscle disease and disordersIMMUNOFORGE CO LTD·Filed 2024·Application pending·0 cites
- 0377US2023414773A1Elp fusion proteins for controlled and sustained releaseIMMUNOFORGE CO LTD·Filed 2023·Application pending·0 cites
- 0476US2024091313A1Modified vasoactive intestinal peptidesIMMUNOFORGE CO LTD·Filed 2023·Application pending·0 cites
- 0572US10993993B2Pharmaceutical composition for treating muscle atrophy or sarcopenia including glucagon-like peptide (GLP-1) or GLP-1 receptor agonistIMMUNOFORGE CO LTD·Filed 2018·Granted May 4, 2021·1 cites·6 claims
- 0666US2024294608A1Elp fusion proteins for controlled and sustained releaseIMMUNOFORGE CO LTD·Filed 2024·Application pending·0 cites
- 0764US2025276072A1Elp fusion proteins for controlled and sustained releaseIMMUNOFORGE CO LTD·Filed 2025·Application pending·0 cites
- 0860US2025289861A1Fusion protein comprising glp-1, immunoglobulin fc, and igf-1 and use thereofIMMUNOFORGE CO LTD·Filed 2023·Application pending·0 cites
- 0948US10751392B2Pharmaceutical composition for treating sarcopenia including glucagon-like peptide-1 receptor agonistIMMUNOFORGE CO LTD·Filed 2016·Granted Aug 25, 2020·0 cites·9 claims
- 1046US2024018209A1Fusion protein including glp-1 receptor agonist, and anti-oscar antibody and use thereofIMMUNOFORGE CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNOFORGE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →